Home
Our ServicesConnect Education Workshops
HomeOur ServicesConnect Education Workshops
The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
Listen Now
Topics Covered
- What’s New in the Treatment of WM
- Symptoms & Signs
- Front Line Treatment of WM
- Treatment for Relapsed/Refractory WM
- Standard of Care & New Treatment Approaches
- Clinical Trial Updates
- Managing Symptoms & Side Effects, including Controlling Complications
- Managing Peripheral Neuropathy
- Key Questions to Ask Your Health Care Team, including Treatment Follow-Up Care
- Quality-of-Life Concerns
- Mapping the Future of WM
- Questions for Our Panel of Experts
Our Panel of Experts
Steven Treon, MD, PhD
Director, Bing Center for Waldenstrom’s Macroglobulinemia, Professor, Harvard Medical School, Dana Farber Cancer Institute
Christian Buske, MD
Medical Director, Comprehensive Cancer Centre and Institute of Experimental Cancer Research, University of Ulm, Attending Physician & Professor of Medicine, Medical Department for Internal Medicine III, Hematology/Oncology, University Hospital, Ulm, Germany
Carl Harrington
Chair, IWMF Board of Trustees, The International Waldenstrom’s Macroglobulinemia Foundation
Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop 
Workshop Date
This workshop was originally recorded on March 19, 2020.